Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. See why I rate the CLOV stock a Buy.

Anwar Galvanizing Limited continues to bleed in its core business amid weak construction demand and supply chain disruptions. Yet, strong gains from capital market investments have helped the listed ...

Palantir's top and bottom lines are both moving in the right direction. Enough investors just need to notice it again.

Apple executives continue to cash in on stock options this month as the company's stock sets record highs. Phil Schiller, Apple's Senior Vice President of Worldwide Product Marketing, has added ...

Former House Speaker Nancy Pelosi and her husband made at least $130 million in stock profits over the course of the California Democrat’s 37 years in Congress — a staggering return of 16,930%. Pelosi ...

If investors could perfectly predict future cash flows, it would be so much easier.

NEW YORK (AP) — The U.S. stock market is drifting near its record heights on Tuesday. The S&P 500 added 0.3% in afternoon trading. The Dow Jones Industrial Average was up 336 points, or 0.7%, as of ...

Intel's latest sell-off has exposed a growing gap between the company's soaring ambitions and its current earnings power. After a powerful run-up in 2025, Bank of America is now arguing that the stock ...

NIO is showing a lot of promise right now, with expectations of its first ever profit in Q4 2025 after robust deliveries in the quarter and expectations of strong revenues. The relatively muted price ...

Freedom Capital Markets analyst Dmitriy Pozdnyakov served up a new stock idea this morning — food delivery robot-maker Serve Robotics (Nasdaq: SERV), which it says is a buy that he predicts will hit ...